Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%
Report ID | 88610 |
Drug Identification Number | 02141019 |
Brand name | CALCIUM GLUCONATE INJECTION, USP 10% |
Common or Proper name | Calcium Gluconate Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CALCIUM GLUCONATE |
Strength(s) | 94MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 100mL Vial |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-27 |
Estimated end date | 2019-07-12 |
Actual end date | 2019-07-24 |
Shortage status | Resolved |
Updated date | 2019-07-26 |
Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption with our Calcium Gluconate Injection, USP 10% 100 mg/mL Vial 100mL. Our Calcium Gluconate Injection, USP 10% 100 mg/mL Vial 50 mL will be available for substitution. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-05 | English | Compare |
v2 | 2019-07-05 | French | Compare |
v3 | 2019-07-26 | English | Compare |
v4 | 2019-07-26 | French | Compare |
Showing 1 to 4 of 4